The research, which was announced this week by Columbia University professor Frank Lichtenberg, found that patients are 2.5% more likely to start and stay on a course of treatment for every 10-year decrease in a drug's time on the market.
The study is supported by a $2.5 million award from the U.S. Department of Defense through the medical technology enterprise consortium. The award is part of the consortium's efforts to keep military personnel healthy by detecting the virus before symptoms emerge.
Northwell Health's $2.5 billion expansion plan for the hospital in Manhattan's Upper East Side, one of New York City's whitest enclaves, faces vehement opposition from healthcare advocates who say the project neglects communities of color.
Manhattan-based biometrics firm Clear—best known for letting people skip to the front of the airport security line—has partnered with the country's two largest private labs to link COVID-19 test results to an app that lets employers and building owners screen at the door for health risks.
The work is especially important as antiretroviral therapy to suppress HIV has helped tens of millions of people live longer and healthier lives. But the unfortunate consequence of living longer with HIV is an increased risk of cancer.
Commercial ambulance providers in New York are used to a small number of calls for which they treat patients at home who don’t need or want to be taken to a hospital. Such instances have skyrocketed during the pandemic, however, and the companies aren’t being reimbursed for them.